Clinical Trial Update: Intravenous Pantoloc In Aspirin-Induced Ulcer Bleeding [NA]

View source ↗

Summary

A completed clinical trial evaluated intravenous pantoprazole (Pantoloc) for aspirin-induced ulcer bleeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Cerebrovascular Disorders

Drugs mentioned

• Pantoloc (pantoprazole)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Cardiovascular Disease, Cerebrovascular Disorders | NA | Status: COMPLETED